Literature DB >> 23806285

Development and validation of a claims-based prediction model for COPD severity.

Dendy Macaulay1, Shawn X Sun, Rachael A Sorg, Sherry Y Yan, Gourab De, Eric Q Wu, Paul F Simonelli.   

Abstract

BACKGROUND: Administrative claims are an important data source for COPD research but lack a validated measure of patient COPD severity, which is an important determinant of treatment and outcomes.
METHODS: Patients with ≥1 diagnosis of COPD and spirometry results from 01/2004-05/2011 were identified from an electronic health records database linked to healthcare claims. Patients were classified into 3 COPD severity groups based on spirometry and Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines: GOLD-Unclassified, Mild/Moderate, and Severe/Very Severe. A multinomial logistic regression model was constructed using claims data from 3 months before and after (observation period) the most recent spirometry (index date) to categorize patient COPD severity. A random selection of 90% of patients in each severity level was selected to build the model, and the remaining 10% were used as a validation sample. Model predictions were evaluated for sensitivity, specificity, accuracy, and concordance.
RESULTS: Among 2028 COPD patients who met sample selection criteria, 886, 683, and 459 patients were in the GOLD-Unclassified, Mild/Moderate, and Severe/Very Severe categories, respectively. The final model included age, sex, comorbidities (such as pulmonary fibrosis and diabetes), COPD-related resource utilization (such as oxygen use), and all-cause healthcare utilization. In the validation sample, the model correctly predicted COPD severity for 62.7% of all patients (accuracy for predicting GOLD-Unclassified: 73.5%; Mild/Moderate: 70.6%; Severe/Very Severe: 81.4%) with kappa = 0.41.
CONCLUSIONS: The prediction model was developed using clinically measured COPD severity to provide researchers an approach to classify patients using claims data when clinical measures are not available.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BMI; COPD; COPD severity; Claims-based; EHR; ER; FEV(1); FVC; GHP; GHS; GOLD; Geisinger Health Plan; Geisinger Health System; Global Initiative for Chronic Obstructive Lung Disease; ICD-9; International Classification of Diseases, Ninth revision; Prediction model; body mass index; chronic obstructive pulmonary disease; electronic health record; emergency room; forced expiratory volume for one second; forced vital capacity

Mesh:

Year:  2013        PMID: 23806285     DOI: 10.1016/j.rmed.2013.05.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.

Authors:  A Afonso; S Schmiedl; C Becker; S Tcherny-Lessenot; P Primatesta; E Plana; P Souverein; Y Wang; J C Korevaar; J Hasford; R Reynolds; M C H de Groot; R Schlienger; O Klungel; M Rottenkolber
Journal:  Eur J Clin Pharmacol       Date:  2016-05-24       Impact factor: 2.953

2.  Benefits of Early Roflumilast Treatment After Hospital or Emergency Department Discharge for a COPD Exacerbation.

Authors:  Qing Lee; Michelle Mocarski; Shawn X Sun
Journal:  Am Health Drug Benefits       Date:  2016-05

3.  The Impact of Care Specialty on Survival-Adjusted Medical Costs of COPD Patients After a Hospitalization: a longitudinal analysis.

Authors:  Wenjia Chen; Don D Sin; J Mark FitzGerald; Mohsen Sadatsafavi
Journal:  J Gen Intern Med       Date:  2018-04-02       Impact factor: 5.128

4.  End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; Christine A Goodrich; Mark T Dransfield; Shama S Alam; Cynthia J Brown; C Seth Landefeld; Marie A Bakitas; Jeremiah R Brown
Journal:  Am J Med       Date:  2019-12-27       Impact factor: 4.965

5.  Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.

Authors:  Subroto Paul; Paul C Lee; Jialin Mao; Abby J Isaacs; Art Sedrakyan
Journal:  BMJ       Date:  2016-07-08

6.  Using medication utilization information to develop an asthma severity classification model.

Authors:  Tsung-Hsien Yu; Pin-Kuei Fu; Yu-Chi Tung
Journal:  BMC Med Inform Decis Mak       Date:  2017-12-20       Impact factor: 2.796

7.  Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study.

Authors:  Theresa M Lee; Karen Tu; Laura L Wing; Andrea S Gershon
Journal:  NPJ Prim Care Respir Med       Date:  2017-05-15       Impact factor: 2.871

8.  Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs.

Authors:  Michael Munsell; Molly Frean; Joseph Menzin; Amy L Phillips
Journal:  BMC Neurol       Date:  2017-06-05       Impact factor: 2.474

9.  Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD.

Authors:  Chad Moretz; Srinivas Annavarapu; Rakesh Luthra; Seth Goldfarb; Andrew Renda; Asif Shaikh; Shuchita Kaila
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-15

10.  Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.

Authors:  Claus F Vogelmeier; Konstantinos Kostikas; Juanzhi Fang; Hengfeng Tian; Bethan Jones; Christopher Ll Morgan; Robert Fogel; Florian S Gutzwiller; Hui Cao
Journal:  Respir Res       Date:  2019-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.